Compare
Doximity vs Solventum (DOCS vs SOLV)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Doximity (DOCS) returned -49.2% and Solventum (SOLV) +33.5%; so far this year the figures are -26.6% and +14.1%.
Solventum is the larger company by market value, about 2.6 times the size of Doximity.
On trailing earnings, DOCS trades at 45.2 times and SOLV at 102.7 times.
Revenue grew +6.5% at DOCS and -2.8% at SOLV over the last year.
Data as of the latest close. Not investment advice.
Relative performance
| DOCS | SOLV | |
|---|---|---|
| Price | $32.51 | $90.38 |
| 1-day | -2.02% | +3.67% |
| YTD | -26.58% | +14.06% |
| 1 year | -49.20% | +33.52% |
| 3 years | +59.91% | — |
| Market cap | $5.8B | $15.3B |
| P/E | 45.2 | 102.7 |
| P/S | 8.76 | 1.88 |
| P/B | 6.24 | 3.19 |
| Revenue growth | +6.50% | -2.80% |
| EPS growth | -42.90% | -89.90% |
| Gross margin % | 86.8 | 54.8 |
| Net margin % | 21.1 | 1.9 |
| ROE % | 15.0 | 3.2 |
| Debt / equity | 0.00 | 1.05 |
| FCF yield % | 5.3 | 0.0 |
| Dividend yield % | — | — |
| Beta | 0.57 | 0.62 |
| RSI (14) | 54.9 | 59.3 |
| Technical rating |